In vitro inhibition of human malignant brain tumour cell line proliferation by anti-urokinase-type plasminogen activator monoclonal antibodies
1998

Inhibition of Brain Tumor Cell Growth by Anti-Urokinase Antibodies

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): M-SI Abaza, FA Shaban, RK Narayan, M Zouhair Atassi

Primary Institution: Baylor College of Medicine

Hypothesis

Can anti-urokinase monoclonal antibodies inhibit the proliferation of human malignant brain tumor cell lines?

Conclusion

Anti-urokinase monoclonal antibodies significantly inhibited the proliferation of glioma cell lines while having minimal effects on normal human cells.

Supporting Evidence

  • Urokinase levels were found to be 5- to 44-fold higher in glioma tissues compared to normal brain tissues.
  • Anti-urokinase monoclonal antibodies inhibited the proliferation of glioma cell lines by up to 99.35%.
  • Normal human liver, intestine, and lymphocyte cell lines showed less than 20% inhibition when treated with the antibodies.

Takeaway

Scientists found that special antibodies can stop brain tumor cells from growing, but they don't hurt normal cells much.

Methodology

The study involved preparing brain tumor extracts and testing the effects of anti-urokinase monoclonal antibodies on glioma cell lines using various assays.

Limitations

The study primarily focused on in vitro conditions, which may not fully represent in vivo scenarios.

Participant Demographics

The study involved glioma patients, but specific demographic details were not provided.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication